Journal Article (Letter)

DKFZ-2022-00338

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.

Holsten, T. ; Bronsema, A. ; Sturm, D.DKFZ* ; Sahm, F.DKFZ* ; Rutkowski, S. ; Schüller, U. ; Wößmann, W. ; Kordes, U. R.

2022
Wiley New York, NY

This record in other databases:  

Please use a persistent id in citations: doi:10.1002/pbc.29594

Note: 2022 Aug;69(8):e29594

---

Contributing Institute(s):

1. B062 Pädiatrische Neuroonkologie (B062)
2. KKE Neuropathologie (B300)
3. DKTK HD zentral (HD01)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2022

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; Essential Science Indicators ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---